COMPOSITION FOR ALLEVIATING CORONAVIRUS INFECTION USING RALOXIFENE

The present invention discloses a composition for alleviating coronavirus infection using raloxifene which has an activity of improving the viability of infected cells of coronaviruses SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, SARS-CoV-2, or of inhibiting the propagation of the coronaviruses within...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KIM, Pan Soo, LEE, Joo Yeon, KIM, Jin Hee, KIM, Kyung Chang, MIN, Ji Young, JEONG, Kwi Wan, CHANG, So Young, PARK, Sun Mi, KIM, Seung Taek, KIM, Young Eui
Format: Patent
Sprache:eng ; fre ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention discloses a composition for alleviating coronavirus infection using raloxifene which has an activity of improving the viability of infected cells of coronaviruses SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, SARS-CoV-2, or of inhibiting the propagation of the coronaviruses within cells. La présente invention concerne une composition pour soulager une infection à coronavirus à l'aide de raloxifène qui a une activité d'amélioration de la viabilité de cellules infectées par les coronavirus SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, SARS-CoV-2, ou d'inhibition de la propagation des coronavirus dans les cellules. 본 발명은 코로나바이러스인 SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, SARS-CoV-2의 감염세포 생존율을 향상시키거나 그 코로나바이러스 세포 내 증식을 억제하는 활성을 가진 랄록시펜을 코로나바이러스 감염증 개선용 조성물을 개시한다.